Literature DB >> 1320675

Benign testicular tumors in children with congenital adrenal hyperplasia.

M S Srikanth1, B R West, M Ishitani, H Isaacs, H Applebaum, G Costin.   

Abstract

The association between testicular tumors/nodules and congenital adrenal hyperplasia (CAH) has been previously reported. From 1960 to 1989, three patients (13 to 18 years old) with long-standing CAH developed testicular masses. Two patients with 21-hydroxylase deficiency were diagnosed in the neonatal period while one other with 11-hydroxylase deficiency was diagnosed at 3 years of age when he presented with sexual precocity. In all three patients, medical compliance was poor. The testicular masses were bilateral in two patients and unilateral in one, measured 1 to 2 cm, and occupied only the upper half of the testicle. Testicular biopsy specimens were obtained after at least 6 months of evidence of compliance with the adrenocorticotrophic hormone (ACTH) suppressive medication and failure of the nodules to regress. On gross examination the masses appeared to be firm yellow brown nodules. Light microscopy showed interlacing strands, cords, and rests of cells resembling interstitial (Leydig) cells but with no Reinke crystalloids. Electronmicroscopy in all patients showed variable amounts of both smooth and rough endoplasmic reticulum, the later with occasional dilated cisternae. Follow-up ranged from 6 months to 6 years. No further surgical treatment has been necessary. There has been no evidence of recurrence, distant metastases, or secondary malignancies during the time of follow-up. These findings suggest that testicular tumors may develop from chronic excessive ACTH stimulation of a putative pluripotential testicular cell, a Leydig cell, or an adrenal cortical rest. Unlike other testicular tumors these do not require orchiectomy as the initial form of therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320675     DOI: 10.1016/0022-3468(92)90466-k

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Robert C Wilson; Saroj Nimkarn; Miro Dumic; Jihad Obeid; Maryam Razzaghy Azar; Maryam Azar; Hossein Najmabadi; Fatemeh Saffari; Maria I New
Journal:  Mol Genet Metab       Date:  2007-02-01       Impact factor: 4.797

2.  Testis sparing surgery for steroid unresponsive testicular tumors of the congenital adrenal hyperplasia.

Authors:  Tuğrul Tiryaki; Zehra Aycan; Sema Hücümenoğlu; Halil Atayurt
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

3.  A patient with refractory testicular adrenal rest tumour in the setting of cyp11b1 deficiency congenital adrenal hyperplasia.

Authors:  Mohammad Reza Mirzaei; Hassan Rezvanian; Mansour Siavash; Mahmoud Parham; Parvin Mahzouni
Journal:  BMJ Case Rep       Date:  2009-04-14

4.  Testicular adrenal rest hyperplasia due to 21-hydroxylase deficiency: a case report.

Authors:  Seyda Erdogan; Melek Ergin; Filiz Cevlik; Bilgin Yuksel; Recep Tuncer; Nurdan Tunali; Sait Polat
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.

Authors:  J Jääskeläinen; O Kiekara; M Hippeläinen; R Voutilainen
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 6.  Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia.

Authors:  A A M Ghazi; F Hadayegh; G Khakpour; F Azizi; J C Melby
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 7.  Congenital adrenal hyperplasia: transition from chil dhood to adulthood.

Authors:  P W Speiser
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

8.  GATA transcription factors in testicular adrenal rest tumours.

Authors:  Manon Engels; Paul N Span; Rod T Mitchell; Joop J T M Heuvel; Monica A Marijnissen-van Zanten; Antonius E van Herwaarden; Christina A Hulsbergen-van de Kaa; Egbert Oosterwijk; Nike M Stikkelbroeck; Lee B Smith; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  Endocr Connect       Date:  2017-10-16       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.